Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

February 1, 2024

https://www.prnewswire.com/news-releases/nuvalent-to-participate-in-the-guggenheim-healthcare-talks-6th-annual-biotechnology-conference-302050153.html

CAMBRIDGE, Mass., Feb. 1, 2024 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024, at 10:30 a.m. ET in NYC.

Read more at prnewswire.com

Related news for (NUVL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.